MedPath

SCIEGEN PHARMACEUTICALS, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

59

FDA:57
SFDA:2

Drug Approvals

Metoclopramide

Approval Date
May 7, 2025
FDA

Clotrimazole Topical Solution USP, 1%

Approval Date
Mar 11, 2024
FDA

Bupropion Hydrochloride

Approval Date
Jan 5, 2024
FDA

Aripiprazole

Approval Date
Nov 10, 2023
FDA

PIRFENIDONE

Approval Date
Nov 9, 2023
FDA

Fluoxetine

Approval Date
Nov 8, 2023
FDA

LACOSAMIDE

Approval Date
Nov 8, 2023
FDA

ATORVASTATIN CALCIUM

Approval Date
Nov 8, 2023
FDA

Pregabalin

Approval Date
Nov 8, 2023
FDA

SERTRALINE HYDROCHLORIDE

Approval Date
Nov 8, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.